Display options
Share it on

Ann Surg Oncol. 1994 Mar;1(2):157-63. doi: 10.1007/BF02303560.

Prevention of chronic radiation enteropathy by dietary glutamine.

Annals of surgical oncology

J C Jensen, R Schaefer, E Nwokedi, D W Bevans, M L Baker, A A Pappas, K C Westbrook, V S Klimberg

Affiliations

  1. Department of Surgery, University of Arkansas for Medical Sciences, Little Rock 72205.

PMID: 7834441 DOI: 10.1007/BF02303560

Abstract

BACKGROUND: Nearly 50% of all cancer patients receive therapeutic radiation during the course of their disease. The risk of late complications is the main dose-limiting factor in the delivery of radiation therapy. The small intestine, the major site of chronic radiation enteropathy, is also the principal organ of glutamine consumption. We therefore hypothesized that the provision of supplemental glutamine may have a protective effect on the development of chronic radiation enteropathy.

METHODS: This study evaluated the effects of supplemental oral glutamine on the development of chronic radiation (XRT) enteropathy. After scrotalization of a loop of small intestine, rats were randomized to receive 1 g/kg/day glutamine (GLN) or glycine (GLY) by gavage. After 2 days of prefeeding, rats were randomized to 1 of 4 groups: GLN + XRT (n = 10), GLY + XRT (n = 10), GLN only (n = 10), GLY only (n = 10). Twenty Gy was delivered to the scrotalized bowel in the GLN + XRT and GLY + XRT groups via a collimated beam. Gavage was continued for 10 days. Animals were then pair-fed chow. Rats were killed at 2 months postirradiation. Chronic radiation injury was assessed microscopically.

RESULTS: Injury scores in GLN + XRT were similar to those of unirradiated bowel and significantly different from GLY + XRT (1.89 +/- 0.48 in XRT + GLN vs. 6.42 +/- 1.55 in the XRT + GLY, p < 0.01). Elevated Injury Scores in the XRT + GLY group correlated with gross thickening and fibrosis, a 10-fold decrease in gut GLN extraction (1.40 +/- 4.3% in GLY + XRT vs. 16.0 +/- 5.1% in GLN + XRT, p < 0.05), and a 30% decrease in glutathione content (2.46 +/- 0.19 and GLY + XRT vs. 3.17 +/- 0.17 GLN + XRT, p < 0.05).

CONCLUSIONS: Provision of GLN during abdominal/pelvic XRT may prevent XRT injury and decrease the long-term complications of radiation enteropathy.

References

  1. Ann Surg. 1980 Apr;191(4):465-72 - PubMed
  2. Arch Biochem Biophys. 1975 Dec;171(2):662-72 - PubMed
  3. J Biol Chem. 1974 Aug 25;249(16):5070-9 - PubMed
  4. Int J Radiat Oncol Biol Phys. 1983 Oct;9(10):1445-50 - PubMed
  5. Cancer. 1990 Jul 1;66(1):62-8 - PubMed
  6. JPEN J Parenter Enteral Nutr. 1985 Sep-Oct;9(5):583-9 - PubMed
  7. Semin Oncol. 1987 Mar;14(1):65-74 - PubMed
  8. Ann Surg. 1969 Sep;170(3):369-84 - PubMed
  9. Int J Radiat Oncol Biol Phys. 1988 Jun;14(6):1205-12 - PubMed
  10. Cancer Res. 1982 Mar;42(3):824-9 - PubMed
  11. Anal Biochem. 1980 Jul 15;106(1):207-12 - PubMed
  12. Can J Biochem. 1979 Mar;57(3):233-7 - PubMed
  13. Arch Surg. 1990 Aug;125(8):1040-5 - PubMed
  14. Cancer Treat Rep. 1977 Aug;61(5):797-804 - PubMed
  15. Cancer Res. 1972 Feb;32(2):326-33 - PubMed
  16. J Biol Chem. 1980 Jan 10;255(1):107-12 - PubMed
  17. Acta Radiol Oncol. 1983;22(4):299-303 - PubMed
  18. Anal Biochem. 1969 Mar;27(3):502-22 - PubMed
  19. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  20. JPEN J Parenter Enteral Nutr. 1985 Sep-Oct;9(5):608-17 - PubMed
  21. Radiat Res. 1970 Jul;43(1):131-42 - PubMed
  22. Am J Surg. 1990 Jan;159(1):27-32; discussion 32-3 - PubMed
  23. Cancer Treat Rep. 1977 Aug;61(5):779-83 - PubMed

Substances

MeSH terms

Publication Types